Application 761456

Type
BLA
Sponsor
AMNEAL PHARMS LLC

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
761456Boncresadenosumab-mobz351(k) InterchangeableRx2026-06-01

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001BONCRESADENOSUMAB-MOBZINJECTABLE;SUBCUTANEOUS60MG/ML NoNo

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 ยท 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
BoncresaDENOSUMAB-MOBZAmneal Pharmaceuticals LLC29140df2-24a3-4a6f-a8e3-065521448d612025-12-22Boxed warning, Warnings, Adverse reactionsExact identifier
application number: BLA761456

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
84689ORIG 2026-01-06
84686ORIG 2026-01-06
84518ORIG 2025-12-23